NCT00629928View on ClinicalTrials.gov

Ulcer Prevention II

PHASE3CompletedINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions

NSAID Associated Gastric Ulcers

Interventions

DRUG

Esomeprazole

20mg oral capsule daily

DRUG

Esomeprazole

40mg oral capsule daily

DRUG

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT00629928 - Ulcer Prevention II | Biotech Hunter | Biotech Hunter